Syncom Formulations (India) Limited has informed the Exchange about General Updates
SYNCOMF · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Syncom Formulations held its 37th AGM on 29th September 2025 via video conferencing from 2:00 PM to 2:30 PM. Six directors, including Chairman Ankit Kedarmal Bankda, Managing Director Vijay Shankarlal Bankda, CFO Rahul Vijay Bankda, and the Company Secretary were present. Eight resolutions were tabled, including adoption of FY25 audited financial statements, ratification of cost auditor remuneration, confirmation of secretarial auditor M/s D.K. Jain & Co., appointment of Ankit Kedarmal Bankda as Executive Chairman and Whole-time Director with remuneration, an increase in CFO Rahul Vijay Bankda's remuneration (a related-party item under Section 188), and alterations to the Articles and Memorandum of Association. The statutory auditors' report had no qualifications or adverse remarks, and 80 shareholders attended the meeting, well above the quorum of 30. E-voting results are awaited within two working days.
This is a routine regulatory filing of AGM proceedings, so it is largely procedural and unlikely to move the stock on its own. The clean audit report and leadership continuity (Ankit Bankda elevated to Executive Chairman) are mildly positive, while the increase in CFO pay is a related-party transaction that shareholders will formally approve via e-voting results, which are due shortly.